93 related articles for article (PubMed ID: 27273463)
1. Incidence and risk factors of bacterial infections in children following autologous hematopoietic stem cell transplantation: Single-center experience from Jordan.
Hussein AA; Al-Antary ET; Najjar R; Al-Zaben A; Frangoul H
Pediatr Transplant; 2016 Aug; 20(5):683-6. PubMed ID: 27273463
[TBL] [Abstract][Full Text] [Related]
2. Incidence and risk factors for cytomegalovirus (CMV) reactivation following autologous hematopoietic stem cell transplantation in children.
Hussein AA; Al-Antary ET; Najjar R; Al-Hamdan DS; Al-Zaben A; Frangoul H
Pediatr Blood Cancer; 2015 Jun; 62(6):1099-101. PubMed ID: 25346146
[TBL] [Abstract][Full Text] [Related]
3. Early infections after autologous hematopoietic stem cell transplantation in children and adolescents: the St. Jude experience.
Srinivasan A; McLaughlin L; Wang C; Srivastava DK; Shook DR; Leung W; Hayden RT
Transpl Infect Dis; 2014 Feb; 16(1):90-7. PubMed ID: 24256514
[TBL] [Abstract][Full Text] [Related]
4. [Infectious complications postengrafment in the first year after autologous stem cell transplantation in children].
Ben Salah H; Coze C; Gentet JC; Lautraite C; André N; Bernard JL
Arch Pediatr; 2005 May; 12(5):526-32. PubMed ID: 15885541
[TBL] [Abstract][Full Text] [Related]
5. Analysis of incidence and risk factors of the multidrug resistant gastrointestinal tract infection in children and adolescents undergoing allogeneic and autologous hematopoietic cell transplantation: a nationwide study.
Salamonowicz-Bodzioch M; Frączkiewicz J; Czyżewski K; Zając-Spychała O; Gorczyńska E; Wróbel G; Kazanowska B; Sęga-Pondel D; Węcławek-Tompol J; Ussowicz M; Kałwak K; Wysocki M; Dziedzic M; Wachowiak J; Zaucha-Prażmo A; Kowalczyk J; Goździk J; Styczyński J
Ann Hematol; 2022 Jan; 101(1):191-201. PubMed ID: 34674000
[TBL] [Abstract][Full Text] [Related]
6. High-dose therapy and autologous hematopoietic stem-cell transplantation does not increase the risk of second neoplasms for patients with Hodgkin's lymphoma: a comparison of conventional therapy alone versus conventional therapy followed by autologous hematopoietic stem-cell transplantation.
Forrest DL; Hogge DE; Nevill TJ; Nantel SH; Barnett MJ; Shepherd JD; Sutherland HJ; Toze CL; Smith CA; Lavoie JC; Song KW; Voss NJ; Gascoyne RD; Connors JM
J Clin Oncol; 2005 Nov; 23(31):7994-8002. PubMed ID: 16204014
[TBL] [Abstract][Full Text] [Related]
7. Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic stem cell transplantation: risk factors analysis and outcome.
Gil L; Styczynski J; Komarnicki M
Infection; 2007 Dec; 35(6):421-7. PubMed ID: 17926001
[TBL] [Abstract][Full Text] [Related]
8. Second malignancy following high-dose therapy and autologous stem cell transplantation: incidence and risk factor analysis.
Forrest DL; Nevill TJ; Naiman SC; Le A; Brockington DA; Barnett MJ; Lavoie JC; Nantel SH; Song KW; Shepherd JD; Sutherland HJ; Toze CL; Davis JH; Hogge DE
Bone Marrow Transplant; 2003 Nov; 32(9):915-23. PubMed ID: 14561993
[TBL] [Abstract][Full Text] [Related]
9. Incidence of infection according to intravenous immunoglobulin use in autologous hematopoietic stem cell transplant recipients with multiple myeloma.
Park S; Jung CW; Jang JH; Kim SJ; Kim WS; Kim K
Transpl Infect Dis; 2015 Oct; 17(5):679-87. PubMed ID: 26201517
[TBL] [Abstract][Full Text] [Related]
10. A low incidence of nontuberculous mycobacterial infections in pediatric hematopoietic stem cell transplantation recipients.
Unal E; Yen C; Saiman L; George D; Della-Latta P; van de Ven C; Morris E; Bradley MB; Del Toro G; Garvin J; Bhatia M; Schwartz J; Satwani P; Roman E; Cooney E; Wolownik K; Hawks R; Foley S; Cairo MS
Biol Blood Marrow Transplant; 2006 Nov; 12(11):1188-97. PubMed ID: 17085312
[TBL] [Abstract][Full Text] [Related]
11. Fluoroquinolone resistance in hematopoietic stem cell transplant recipients with infectious complications.
Bonadio M; Morelli G; Mori S; Riccioni R; Papineschi F; Petrini M
Biomed Pharmacother; 2005 Oct; 59(9):511-6. PubMed ID: 16274955
[TBL] [Abstract][Full Text] [Related]
12. Aerobic bacterial and fungal infections in peripheral blood stem cell transplants.
Aksu G; Ruhi MZ; Akan H; Bengisun S; Ustün C; Arslan O; Ozenci H
Bone Marrow Transplant; 2001 Jan; 27(2):201-5. PubMed ID: 11281391
[TBL] [Abstract][Full Text] [Related]
13. Invasive aspergillosis and allogeneic hematopoietic stem cell transplantation in children: a 15-year experience.
Crassard N; Hadden H; Pondarré C; Hadden R; Galambrun C; Piens MA; Pracros JP; Souillet G; Basset T; Berthier JC; Philippe N; Bertrand Y
Transpl Infect Dis; 2008 Jun; 10(3):177-83. PubMed ID: 18331389
[TBL] [Abstract][Full Text] [Related]
14. [Epidemiology of early infections after autologous hematopoietic stem cell transplantation.
Lakatos B; Szabó H; Csordás K; Tatai G; Nikolova R; Csomor J; Reményi P; Masszi T; Vályi-Nagy I; Sinkó J
Orv Hetil; 2020 Jan; 161(3):103-109. PubMed ID: 31928060
[TBL] [Abstract][Full Text] [Related]
15. Infectious complications in the first year following autologous hematopoietic progenitor cell rescue for children with brain tumors.
Brown RJ; Rahim H; Wong KE; Cooper RM; Marachelian A; Butturini A; Dhall G; Finlay JL
Pediatr Blood Cancer; 2013 Dec; 60(12):2012-7. PubMed ID: 23956157
[TBL] [Abstract][Full Text] [Related]
16. Early infections in patients undergoing bone marrow or blood stem cell transplantation--a 7 year single centre investigation of 409 cases.
Krüger W; Rüssmann B; Kröger N; Salomon C; Ekopf N; Elsner HA; Kaulfers PM; Mack D; Fuchs N; Dürken M; Kabisch H; Erttmann R; Zander AR
Bone Marrow Transplant; 1999 Mar; 23(6):589-97. PubMed ID: 10217190
[TBL] [Abstract][Full Text] [Related]
17. Impact of a change in protected environment on the occurrence of severe bacterial and fungal infections in children undergoing hematopoietic stem cell transplantation.
Libbrecht C; Goutagny MP; Bacchetta J; Ploton C; Bienvenu AL; Bleyzac N; Mialou V; Bertrand Y; Domenech C
Eur J Haematol; 2016 Jul; 97(1):70-7. PubMed ID: 26380877
[TBL] [Abstract][Full Text] [Related]
18. Children post liver transplantation hospitalized with fever are at a high risk for bacterial infections.
Ashkenazi-Hoffnung L; Mozer-Glassberg Y; Bilavsky E; Yassin R; Shamir R; Amir J
Transpl Infect Dis; 2016 Jun; 18(3):333-40. PubMed ID: 26989885
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in the immunoregulatory genes are associated with hematopoietic recovery and increased susceptibility to bacterial infections in patients with thalassaemia major undergoing matched related hematopoietic stem cell transplantation.
Sellathamby S; Lakshmi KM; Busson M; Viswabandya A; George B; Mathews V; Chandy M; Charron D; Krishnamoorthy R; Tamouza R; Srivastava A
Biol Blood Marrow Transplant; 2012 Aug; 18(8):1219-26. PubMed ID: 22252124
[TBL] [Abstract][Full Text] [Related]
20. Infection after pediatric heart transplantation: results of a multiinstitutional study. The Pediatric Heart Transplant Study Group.
Schowengerdt KO; Naftel DC; Seib PM; Pearce FB; Addonizio LJ; Kirklin JK; Morrow WR
J Heart Lung Transplant; 1997 Dec; 16(12):1207-16. PubMed ID: 9436132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
